2026-05-06 06:35Press release

ImmuneBiotech tar strategiskt kliv in i Kina med GutMagnific®

Shahram Lavasani, vd för Immune Biotech, och Mme Yao, affärsansvarig med koppling till Boao Super Hospital i Hainan

Lundbaserade ImmuneBiotech har nått ett viktigt genombrott i Kina genom lanseringen av sin precisionsprobiotika GutMagnific® i Hainan-provinsen. Produkten har introducerats inom Boao Lecheng International Medical Tourism Pilot Zone – ofta kallad Kinas “Medical Silicon Valley” – en unik plattform för avancerad innovation inom hälsoområdet.

Lanseringen möjliggör kommersiell introduktion i en av världens snabbast växande marknader för probiotika. Initiala leveranser har redan genomförts och visar på tidig efterfrågan. Parallellt inleder bolaget kliniska samarbeten i regionen för att ytterligare stärka den vetenskapliga positionen.

Med regulatoriskt godkännande för import och användning, samt patent, varumärkesskydd och etablerad infrastruktur, har ImmuneBiotech redan etablerat försäljning och påbörjat skalning av sin verksamhet i Kina.

ImmuneBiotech är ett av SmiLes alumnibolag.

För mer information, läs hela pressmeddelandet här.

Advancing Swedish Innovation into Global Markets
GutMagnific®, developed by ImmuneBiotech, is a clinically validated, multi-strain precision probiotic designed to restore gut microbiome balance, strengthen the intestinal barrier, and modulate immune function.
Building on its successful commercialization in Sweden, including national availability through Apoteket AB and MEDS Apotek, GutMagnific® is now expanding across EU markets and has established initial commercial traction in the United States, forming a foundation for further expansion as part of the company’s international scale-up strategy.

About ImmuneBiotech
ImmuneBiotech Medical Sweden AB is a Swedish biotechnology company based in Lund, focused on developing microbiome-based health solutions. With over two decades of research in immunology and the gut microbiome, the company is advancing a new category of precision probiotics targeting systemic health.

For further information, please contact:
Shahram Lavasani, CEO
ImmuneBiotech Medical Sweden AB
s.lavasani@immunebiotech.com
+46 700 90 8946
www.ImmuneBiotech.com
Learn more and purchase GutMagnific® at:
www.GutMagnific.com

Language: Swedish

About SmiLe Venture Hub – Pioneering Life Science and Foodtech Innovations

SmiLe is a leading venture hub that specializes in advancing life science and foodtech startups from concept to commercialization. We offer comprehensive support through every stage of entrepreneurship, including tailored incubation and acceleration programs, a variety of educational courses, and access to top-tier lab facilities. To date, our flagship incubator program has supported over 120 startups, facilitating their collective acquisition of more than EUR 1.22 billion in venture capital and contributing to 21 successful IPOs. Recognized as one of Europe’s leading startup hubs in 2024 by the Financial Times and Statista, SmiLe continues to be a catalyst for innovation in the life sciences sector. As a non-profit entity based in Lund, Sweden, SmiLe is supported by Region Skåne, Lund Municipality, Lund University, and Medicon Village. We are also backed by our partners Agilent, Sparbanken Skåne, Høiberg, Setterwalls, Zacco, Key2Compliance, Phase Holographic Imaging, ChemoMetec, Samplix, Qiagen, Bio-Rad, Zeiss, SmartStone Nordics, Säkra, Servier and AbbVie Scandinavia. For more information: www.smileventurehub.com